Apoptotic effect of noscapine in breast cancer cell lines

Quisbert-Valenzuela,Edwin  O.; Calaf,Gloria  M.

doi:10.3892/ijo.2016.3476

Apoptotic effect of noscapine in breast cancer cell lines

Authors:
- Edwin O. Quisbert-Valenzuela
- Gloria M. Calaf
View Affiliations

Affiliations: Institute for Advanced Research, University of Tarapacá, Arica 8097877, Chile
Published online on: April 7, 2016 https://doi.org/10.3892/ijo.2016.3476
Pages: 2666-2674

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cancer is a public health problem in the world and breast cancer is the most frequently cancer in women. Approximately 15% of the breast cancers are triple-negative. Apoptosis regulates normal growth, homeostasis, development, embryogenesis and appropriate strategy to treat cancer. Bax is a protein pro-apoptotic enhancer of apoptosis in contrast to Bcl-2 with antiapoptotic properties. Initiator caspase-9 and caspase-8 are features of intrinsic and extrinsic apoptosis pathway, respectively. NF-κB is a transcription factor known to be involved in the initiation and progression of breast cancer. Noscapine, an alkaloid derived from opium is used as antitussive and showed antitumor properties that induced apoptosis in cancer cell lines. The aim of the present study was to determine the apoptotic effect of noscapine in breast cancer cell lines compared to breast normal cell line. Three cell lines were used: i) a control breast cell line MCF-10F; ii) a luminal-like adenocarcinoma triple-positive breast cell line MCF-7; iii) breast cancer triple-negative cell line MDA-MB-231. Our results showed that noscapine had lower toxicity in normal cells and was an effective anticancer agent that induced apoptosis in breast cancer cells because it increases Bax gene and protein expression in three cell lines, while decreases Bcl-xL gene expression, and Bcl-2 protein expression decreased in breast cancer cell lines. Therefore, Bax/Bcl-2 ratio increased in the three cell lines. This drug increased caspase-9 gene expression in breast cancer cell lines and caspase-8 gene expression increased in MCF-10F and MDA-MB-231. Furthermore, it increased cleavage of caspase-8, suggesting that noscapine-induced apoptosis is probably due to the involvement of extrinsic and intrinsic apoptosis pathways. Antiapoptotic gene and protein expression diminished and proapoptotic gene and protein expression increased noscapine-induced expression, probably due to decrease in NF-κB gene and protein expression and also by increase of IκBα gene expression induced by this drug.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
2	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
3	Tao Z, Shi A, Lu C, Song T, Zhang Z and Zhao J: Breast cancer: Epidemiology and etiology. Cell Biochem Biophys. 72:333–338. 2015. View Article : Google Scholar
4	Cadoo KA, Fornier MN and Morris PG: Biological subtypes of breast cancer: Current concepts and implications for recurrence patterns. Q J Nucl Med Mol Imaging. 57:312–321. 2013.PubMed/NCBI
5	Wong RS: Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011. View Article : Google Scholar : PubMed/NCBI
6	Sharifi S, Barar J, Hejazi MS and Samadi N: Doxorubicin changes Bax/Bcl-xL ratio, caspase-8 and 9 in breast cancer cells. Adv Pharm Bull. 5:351–359. 2015. View Article : Google Scholar : PubMed/NCBI
7	Ravi M, Tentu S, Baskar G, Rohan Prasad S, Raghavan S, Jayaprakash P, Jeyakanthan J, Rayala SK and Venkatraman G: Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells. BMC Cancer. 15:7682015. View Article : Google Scholar : PubMed/NCBI
8	Li MX and Dewson G: Mitochondria and apoptosis: Emerging concepts. F1000Prime Rep. 7:422015.PubMed/NCBI
9	Bargou RC, Daniel PT, Mapara MY, Bommert K, Wagener C, Kallinich B, Royer HD and Dörken B: Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer. 60:854–859. 1995. View Article : Google Scholar : PubMed/NCBI
10	Vela L and Marzo I: Bcl-2 family of proteins as drug targets for cancer chemotherapy: The long way of BH3 mimetics from bench to bedside. Curr Opin Pharmacol. 23:74–81. 2015. View Article : Google Scholar : PubMed/NCBI
11	Besbes S, Mirshahi M, Pocard M and Billard C: New dimension in therapeutic targeting of BCL-2 family proteins. Oncotarget. 6:12862–12871. 2015. View Article : Google Scholar : PubMed/NCBI
12	Bai L and Wang S: Targeting apoptosis pathways for new cancer therapeutics. Annu Rev Med. 65:139–155. 2014. View Article : Google Scholar
13	Hata AN, Engelman JA and Faber AC: The BCL2 family: Key mediators of the apoptotic response to targeted anticancer therapeutics. Cancer Discov. 5:475–487. 2015. View Article : Google Scholar : PubMed/NCBI
14	Hassan M, Watari H, AbuAlmaaty A, Ohba Y and Sakuragi N: Apoptosis and molecular targeting therapy in cancer. Biomed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
15	Cao Y and Karin M: NF-kappaB in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia. 8:215–223. 2003. View Article : Google Scholar : PubMed/NCBI
16	Khan S, Lopez-Dee Z, Kumar R and Ling J: Activation of NF-κB is a novel mechanism of pro-survival activity of glucocorticoids in breast cancer cells. Cancer Lett. 337:90–95. 2013. View Article : Google Scholar : PubMed/NCBI
17	Wang W, Nag SA and Zhang R: Targeting the NF-κB signaling pathways for breast cancer prevention and therapy. Curr Med Chem. 22:264–289. 2015. View Article : Google Scholar
18	Ye K, Ke Y, Keshava N, Shanks J, Kapp JA, Tekmal RR, Petros J and Joshi HC: Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells. Proc Natl Acad Sci USA. 95:1601–1606. 1998. View Article : Google Scholar : PubMed/NCBI
19	Mahmoudian M and Rahimi-Moghaddam P: The anti-cancer activity of noscapine: A review. Recent Patents Anticancer Drug Discov. 4:92–97. 2009. View Article : Google Scholar
20	Li S, He J, Li S, Cao G, Tang S, Tong Q and Joshi HC: Noscapine induced apoptosis via downregulation of survivin in human neuroblastoma cells having wild type or null p53. PLoS One. 7:e400762012. View Article : Google Scholar : PubMed/NCBI
21	Aneja R, Vangapandu SN, Lopus M, Viswesarappa VG, Dhiman N, Verma A, Chandra R, Panda D and Joshi HC: Synthesis of micro-tubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death. Biochem Pharmacol. 72:415–426. 2006. View Article : Google Scholar : PubMed/NCBI
22	Chougule MB, Patel AR, Jackson T and Singh M: Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer. PLoS One. 6:e177332011. View Article : Google Scholar : PubMed/NCBI
23	Yang ZR, Liu M, Peng XL, Lei XF, Zhang JX and Dong WG: Noscapine induces mitochondria-mediated apoptosis in human colon cancer cells in vivo and in vitro. Biochem Biophys Res Commun. 421:627–633. 2012. View Article : Google Scholar : PubMed/NCBI
24	Afzali M, Ghaeli P, Khanavi M, Parsa M, Montazeri H, Ghahremani MH and Ostad SN: Non-addictive opium alkaloids selectively induce apoptosis in cancer cells compared to normal cells. Daru. 23:162015. View Article : Google Scholar : PubMed/NCBI
25	Liu M, Luo XJ, Liao F, Lei XF and Dong WG: Noscapine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo. Cancer Chemother Pharmacol. 67:605–612. 2011. View Article : Google Scholar
26	Chougule M, Patel AR, Sachdeva P, Jackson T and Singh M: Anticancer activity of Noscapine, an opioid alkaloid in combination with cisplatin in human non-small cell lung cancer. Lung Cancer. 71:271–282. 2011. View Article : Google Scholar :
27	Heidari N, Goliaei B, Moghaddam PR, Rahbar-Roshandel N and Mahmoudian M: Apoptotic pathway induced by noscapine in human myelogenous leukemic cells. Anticancer Drugs. 18:1139–1147. 2007. View Article : Google Scholar : PubMed/NCBI
28	Gonçalves A, Braguer D, Carles G, André N, Prevôt C and Briand C: Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4). Biochem Pharmacol. 60:1579–1584. 2000. View Article : Google Scholar : PubMed/NCBI
29	Barham W, Chen L, Tikhomirov O, Onishko H, Gleaves L, Stricker TP, Blackwell TS and Yull FE: Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ. BMC Cancer. 15:6472015. View Article : Google Scholar
30	Li F, Zhang J, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Kumar AP, Ahn KS and Sethi G: NF-κB in cancer therapy. Arch Toxicol. 89:711–731. 2015. View Article : Google Scholar : PubMed/NCBI
31	Sethi G, Ahn KS and Aggarwal BB: Targeting nuclear factor-kappa B activation pathway by thymoquinone: Role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res. 6:1059–1070. 2008. View Article : Google Scholar : PubMed/NCBI
32	Sung B, Ahn KS and Aggarwal BB: Noscapine, a benzyliso-quinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-kappaB signaling pathway. Cancer Res. 70:3259–3268. 2010. View Article : Google Scholar : PubMed/NCBI
33	Cogswell PC, Guttridge DC, Funkhouser WK and Baldwin AS Jr: Selective activation of NF-kappa B subunits in human breast cancer: Potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene. 19:1123–1131. 2000. View Article : Google Scholar : PubMed/NCBI
34	Wertz IE: TNFR1-activated NF-κB signal transduction: Regulation by the ubiquitin/proteasome system. Curr Opin Chem Biol. 23:71–77. 2014. View Article : Google Scholar : PubMed/NCBI